Ypsomed Holding AG (0QLQ.L)

339,03 -13,00 (-3,69%) Alla chiusura: 06:13PM BST

Ypsomed Holding AG

Brunnmattstrasse 6
Burgdorf 3401
Switzerland
41 34 424 41 11
https://www.ypsomed.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 2.200

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Simon Michel	Member of the Board	1,14M	N/D	1977
Mr. Niklaus Ramseier	Chief Financial Officer	N/D	N/D	1963
Mr. Frank Mengis	Chief Operating Officer	N/D	N/D	1964
Thomas Kutt	Head of Investor Relations	N/D	N/D	N/D
Dr. Nicolas Meyer	Chief Legal Officer	N/D	N/D	1971
Mr. Michael Zaugg	Chief Corporate Officer	N/D	N/D	1972
Ms. Ulrike Bauer	Chief Business Officer of Ypsomed Delivery Systems	N/D	N/D	1969
Mr. Sebastien Delarive	Chief Business Officer of Ypsomed Diabetes Care	N/D	N/D	1969

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in CHF.

Descrizione

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Governance aziendale

L'ISS Governance QualityScore di Ypsomed Holding AG al 1 aprile 2024 è 6. I criteri di valutazione fondamentali sono revisione: 7; Consiglio di Amministrazione: 3; diritti degli azionisti: 6; retribuzione: 10.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.